Bridging the gap between the promise of technology and reality - Lokavant's hopes for SCOPE 24-Jan-2024 By Liza Laws Andrew Mills, executive vice president of global commercial Lokavant and says the company can help businesses identify risk trends in trials much earlier than traditional methods.
Lokavant receives $8 million from investment giant, Mitsui to expand AI platform 05-Oct-2023 By Liza Laws Clinical trial platform company, Lokavant, has received an $8 million strategic investment from global trading and investment giant, Mitsui & Co. Ltd.